These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11762153)

  • 21. Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women.
    Nagata C; Nagao Y; Shibuya C; Kashiki Y; Shimizu H
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):705-8. PubMed ID: 15767353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the extracellular matrix in periurethral tissue of women with stress urinary incontinence.
    Goepel C; Thomssen C
    Acta Histochem; 2006; 108(6):441-5. PubMed ID: 16962646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women.
    Wu WH; Lu SC; Wang TF; Jou HJ; Wang TA
    Eur J Clin Nutr; 2006 Mar; 60(3):386-92. PubMed ID: 16278686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of middle-aged and elderly women with urinary incontinence.
    Rohr G; Støvring H; Christensen K; Gaist D; Nybo H; Kragstrup J
    Scand J Prim Health Care; 2005 Dec; 23(4):203-8. PubMed ID: 16272067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low and ultra low-dose estrogen therapy for climacteric symptom control--preliminary report.
    Carranza-Lira S; Gooch AL; Velasco-Díaz G; Solano J; Arzola-Paniagua A
    Int J Fertil Womens Med; 2006; 51(4):171-5. PubMed ID: 17184102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term use of ovestin by postmenopausal women with urinary incontinence].
    D'iakov VV; Godunov BN; Gvozdev MIu
    Urologiia; 2003; (1):43-6. PubMed ID: 12621967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endocrinological changes in pre- and postmenopause].
    von Holst T
    Ther Umsch; 1994 Nov; 51(11):722-8. PubMed ID: 7839330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up.
    Hoşcan MB; Dilmen C; Perk H; Soyupek S; Armağan A; Tükel O; Ekinci M
    Urol Int; 2008; 81(2):167-72. PubMed ID: 18758214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of and potential risk factors for female urinary incontinence in Beijing, China.
    Zhu L; Lang J; Wang H; Han S; Huang J
    Menopause; 2008; 15(3):566-9. PubMed ID: 18467955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of overactive bladder, stress and mixed urinary incontinence on quality of life in Thai postmenopausal women.
    Bunyavejchevin S
    J Med Assoc Thai; 2006 Mar; 89(3):294-8. PubMed ID: 16696411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for stress, urge or mixed urinary incontinence in Italy.
    Parazzini F; Chiaffarino F; Lavezzari M; Giambanco V;
    BJOG; 2003 Oct; 110(10):927-33. PubMed ID: 14550363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary enterolactone affects androgen and estrogen levels in healthy postmenopausal women.
    Granata OM; Traina A; Ramirez S; Campisi I; Zarcone M; Amodio R; Polito LM; Carruba G
    Ann N Y Acad Sci; 2009 Feb; 1155():232-6. PubMed ID: 19250209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring seven endogenous ketolic estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry.
    Xu X; Keefer LK; Waterhouse DJ; Saavedra JE; Veenstra TD; Ziegler RG
    Anal Chem; 2004 Oct; 76(19):5829-36. PubMed ID: 15456304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stress urinary incontinence: an overview on actual surgical trends].
    Perrone A; Tinelli A; Menis T; Lukanovic A; Barbic M; Rakar S; Wiesenfeld U; Tinelli R; Tinelli FG
    Minerva Ginecol; 2003 Feb; 55(1):25-36. PubMed ID: 12598840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of estrogen therapy on hearing in postmenopausal women.
    Kilicdag EB; Yavuz H; Bagis T; Tarim E; Erkan AN; Kazanci F
    Am J Obstet Gynecol; 2004 Jan; 190(1):77-82. PubMed ID: 14749639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women.
    Hirshman E; Merritt P; Wang CC; Wierman M; Budescu DV; Kohrt W; Templin JL; Bhasin S
    Horm Behav; 2004 Feb; 45(2):144-55. PubMed ID: 15019802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of raloxifene on urinary incontinence: a randomized controlled trial.
    Waetjen LE; Brown JS; Modelska K; Blackwell T; Vittinghoff E; Cummings SR;
    Obstet Gynecol; 2004 Feb; 103(2):261-6. PubMed ID: 14754693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary incontinence in nulliparous women and their parous sisters.
    Buchsbaum GM; Duecy EE; Kerr LA; Huang LS; Guzick DS
    Obstet Gynecol; 2005 Dec; 106(6):1253-8. PubMed ID: 16319249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Conservative treatment of urinary incontinence in women].
    Heisterberg L; Molin J; Steen A; Gjørup PA
    Ugeskr Laeger; 1987 Nov; 149(45):3042-4. PubMed ID: 3433504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.